Talk:IMS Health/Archives/2015
This is an archive of past discussions about IMS Health. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
Updates on outdated content
Part of an edit requested by an editor with a conflict of interest has been implemented. |
Hi Jytdog, Blue Rasberry, and Formerly 98,
I'm an employee of IMS Health; I'd like to suggest some edits to the page (mainly from the perspective of updating information). In accordance with WP:COI, I'm not updating the page directly; please let me know your thoughts on the below edits and whether you'd be comfortable with including this information.
Protein3EFN (talk) 14:46, 24 April 2015 (UTC)
Company Infobox
Number of employees: To be changed from 9300 to 10,000+
Under products: Add "Technology Services"
[Sources: https://www.linkedin.com/company/ims-health, http://www.imshealth.com/portal/site/imshealth/menuitem.051a1939316f851e170417041ad8c22a/?vgnextoid=7311e590cb4dc310VgnVCM100000a48d2ca2RCRD]
- When it comes to employee count in the infobox, this changes each year and I encourage you to update it directly, using the company's annual reports or other official data (not linkedin) CorporateM (Talk) 05:10, 25 July 2015 (UTC)
First paragraph of the Business Model section:
Original Text
IMS Health Holdings Inc. reported earning $2.5 billion in 2013, with $1.5 billion in information sales and $1 billion in technology services.[1][2]
Proposed Text
IMS Health Holdings Inc. reported earning $2.6 billion in 2014, with $1.5 billion from information sales and $1.1 billion from technology services. [3]
- Not done I just removed it. I prefer to avoid redundancies with the infobox. Like above, you should feel free to keep the infobox data for revenue up to date each year CorporateM (Talk) 05:13, 25 July 2015 (UTC)
Article lead:
Original Text
In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners.[4] Ari Bousbib is IMS Health’s Chairman and CEO. Bousbib, formerly a longtime senior executive at United Technologies Corporation,[5] joined the company in September 2010.[6]
Proposed Text
In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners.[4] The company went public on April 4th, 2014 and it began trading on the NYSE under the symbol IMS.[7] Ari Bousbib is IMS Health’s Chairman and CEO. Bousbib, formerly a longtime senior executive at United Technologies Corporation,[5] joined the company in September 2010.[6]
- Not done The proposed text appears to be in the article now already. CorporateM (Talk) 05:14, 25 July 2015 (UTC)
Second paragraph of the Business Model section:
Original Text
IMS Health is best known for its collection of healthcare information spanning sales, de-identified prescription data, medical claims, electronic medical records[8] and social media.[9] IMS Health’s products and services are used by companies to develop commercialization plans[10] and portfolio strategies,[11] to select patient and physician populations for specific therapies, and to measure the effectiveness of pharmaceutical marketing and sales resources.[12]
Proposed Text
IMS Health is best known for its collection of healthcare information spanning sales, de-identified prescription data, medical claims, electronic medical records[8] and social media.[9] The company made a series of acquisitions in 2013 and 2014 as a part of its transformation into a technology services company. IMS Health’s products and services are used by companies to develop commercialization plans[10] and portfolio strategies,[11] to select patient and physician populations for specific therapies, and to measure the effectiveness of pharmaceutical marketing and sales resources.[12]
[Sources: List of acquisitions in the History and Acquisitions section]
- Not done No source provided and the text belongs under corporate history CorporateM (Talk) 05:15, 25 July 2015 (UTC)
References
- ^ http://www.sec.gov/Archives/edgar/data/1595262/000119312514000659/d628679ds1.htm
- ^ Ornstein, Charles (10 January 2014). "Big Data + Big Pharma = Big Money". portside.org. Retrieved 5 February 2014.
- ^ http://ir.imshealth.com/files/doc_financials/2014/IMS_2014_AnnualReport_Final.pdf
- ^ a b "IMS Health sold to TPG, CPPIB, LG&P"
- ^ a b "CEO's of Tomorrow"
- ^ a b http://www.businessweek.com/magazine/content/10_36/b4193016891032.htm
- ^ http://venturebeat.com/2014/04/04/ims-health-raises-1-3b-in-2014s-second-biggest-ipo/
- ^ a b http://blogs.wsj.com/health/2009/11/05/what-does-ims-health-do-anyway
- ^ a b http://www.forbes.com/sites/danmunro/2014/01/21/new-study-ranks-johnson-johnson-1-in-pharma-for-social-media-engagement/
- ^ a b Drive to Develop New Commercial Models.pdf "The Drive to Develop New Commercial Models"
- ^ a b in the News/Documents/Kleinrock, 2011 CA Biomed Industry Report_FINAL.pdf "CA Biomed Industry Report"
- ^ a b Market Maps TL.pdf "Patient Market Maps"